These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1465830

  • 1. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z, Adam K, Parapanissiou E, Sakellariou G, Papakyriazi E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced renal graft survival in HLA-A mismatched transplants.
    Bućin D, Ekberg H, Lindholm A, Persson H, Tufvesson G, Albrechtsen D.
    Transplant Proc; 1992 Dec; 24(6):2473-4. PubMed ID: 1465837
    [No Abstract] [Full Text] [Related]

  • 3. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B, Ekberg H, Johnson U.
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract] [Full Text] [Related]

  • 4. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E, Berthoux F, Acquart S, Lepetit JC.
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract] [Full Text] [Related]

  • 5. HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
    Adam K, Polymenidis Z, Papakyriazi L, Alexopoulos E, Parapanissiou E, Antoniadis A, Papadimitriou M.
    Transplant Proc; 1992 Dec; 24(6):2449-50. PubMed ID: 1465825
    [No Abstract] [Full Text] [Related]

  • 6. Very low frequency of rejection due to HLA-(A+)B+DQ matching.
    Christiaans MH, van den Berg-Loonen PM, Nieman FH, van Hooff JP.
    Transplant Proc; 1992 Dec; 24(6):2441-2. PubMed ID: 1465822
    [No Abstract] [Full Text] [Related]

  • 7. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
    Leivestad T, Berger L, Thorsby E.
    Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
    [No Abstract] [Full Text] [Related]

  • 8. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
    Mjörnstedt L, Konar J, Skarp I, Olausson M, Sandberg L, Tufvesson G.
    Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
    [No Abstract] [Full Text] [Related]

  • 9. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J, Schreuder GM, Persijn GG, van Rood JJ.
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract] [Full Text] [Related]

  • 10. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
    Arbelaez M, Mejia G, Henao JE, Garcia A, Arango JL, Velasquez A, Restrepo J, Garcia LF.
    Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
    [No Abstract] [Full Text] [Related]

  • 11. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
    Gnant MF, Sautner T, Rosenmayr A, Muehlbacher F.
    Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
    [No Abstract] [Full Text] [Related]

  • 12. HLA-DR matching defined by SSO-typing in heart transplantation.
    Poli F, Scalamogna M, Pappalettera M, Mascaretti L, Nocco A, Crespiatico L, Sirchia G.
    Transplant Proc; 1992 Dec; 24(6):2436-7. PubMed ID: 1465820
    [No Abstract] [Full Text] [Related]

  • 13. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
    Offermann G, Bünte S, Angelides U, Geidner U, Kirschbaum B, Müller E, Wendt N.
    Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
    [No Abstract] [Full Text] [Related]

  • 14. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea.
    Park K, Kim YS, Kim SI.
    Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816
    [No Abstract] [Full Text] [Related]

  • 15. DR6 compatibility and kidney graft survival.
    Correia AM, de Costa AG, Reis P, Rego F, Sampaio MJ, Caetano JM, Pena JR.
    Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836
    [No Abstract] [Full Text] [Related]

  • 16. Matching for HLA-DPB1 alleles in zero mismatched HLA-A, -B, and -DR renal transplants.
    Middleton D, Mytilineos Y, Savage D, Ferrara GB, Angelini G, Amoroso A, Trainor F, Gaweco A, Mazzola G, Delfino L.
    Transplant Proc; 1992 Dec; 24(6):2439-40. PubMed ID: 1361255
    [No Abstract] [Full Text] [Related]

  • 17. Elective cyclosporine withdrawal in renal transplant recipients maintained on triple therapy.
    Keitel E, Bittar AE, Losekann A, Deboni L, Ceretta F, Goldani JC, Garcia VD.
    Transplant Proc; 1992 Dec; 24(6):2606-8. PubMed ID: 1465881
    [No Abstract] [Full Text] [Related]

  • 18. The relevance of HLA A,B,C, matching on graft survival, patient survival, and graft function in living related renal transplant patients treated with cyclosporine.
    Masri MA, Dhawan IK, Hayes K, Zahir M, Shanwaz M, Shakuntala S, Pingle A.
    Transplant Proc; 1992 Oct; 24(5):1676-7. PubMed ID: 1412793
    [No Abstract] [Full Text] [Related]

  • 19. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
    Middleton D, Martin J, Magee BA, Douglas JF.
    Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
    [No Abstract] [Full Text] [Related]

  • 20. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation.
    Pallardó LM, Sánchez J, Sánchez P, García J, Orero E, Beneyto I, Ros F.
    Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.